Covalently bound conjugates of human serum albumin and heparin were prepared as compounds which could improve the blood-compatibility of polymer surfaces either by preadsorption or by covalent coupling ofthe conjugates onto blood contacting surfaces. The conjugates (lo-16 weight % of heparin) were obtained by a condensation reaction between albumin and heparin using 1-ethyl-3-(dimethylaminopropyl)-carbodiimide. Unreacted albumin and heparin were removed bydiethylaminoethyl (DEAE)-cellulose and Cibacron Blue Sepharose chromatography respectively. The activity of the heparin component incorporated in the albumin-heparin conjugates (AC) was compared with that of the heparin used for the synthesis of the conjugates (Anat) by thrombin time, inhibition of Factor Xa and the activated partial thromboplastin time (APTT) assays. The Ac/Anat ratio for the above assays was as follows: Thrombin time 1.25, Factor Xa inhibition 0.5. and APTT 0.5. Gel filtration chromatography showed broadmolecular weight distributions. The conjugates were fractionated using immobilized antithrombin III (ATIII).
INTRODUCTION
Much effort has been made to improve the blood compatibility of materials by treatment of surfaces using either heparin or human serum albumin. Human serum albumin reduces both the adhesion of blood platelets and the activation Keywords: albumin-heparin conjugates, heparin, anticoagulant activity, antithrombin III.
Synthesis and Fractionation of Conjugates
In a typical experiment, heparin (770 mg)and albumin (2590 mg) were dissolved in water (39 ml) and this solution was adjusted to pH 5.1-5.2 with HCl (1N). During the addition of 1 N HCl, a white precipitate was formed, which contained both heparin and albumin (5). The precipitate dissolved almost completely within 1 hour. Eight 1 ml portions of EDC (c = 32.5 mg/ml) solution were added to the resulting solution at 30 minute intervals. The pH was maintained at 5.1-5.2 by the addition of HCl (1 N) or NaOH (1N). Thirty minutes after the last addition of EDC, the pH was adjusted to pH 7.5 with NaOH (1 N) and the solution was gently stirred for 20 hours. Finally the solution was dialyzed for 2 hours against 0.025 M Tris-HCl, pH 7.5. The total experiment was performed at room temperature.
Separation of the albumin-heparin conjugate from free albumin and heparin was achieved by the following chromatographic procedures. The dialyzed Vo1.29 
Determination of Heparin Concentrations
Heparin concentrations of the different column eluates were routinely determined according to a slightly modified metachromic assay described by Jacques et al. (8) . To a solution of Azure A (3 ml, OD 505 nm f 0.8) in barbital buffer (pH 8.6, ionic strength 0.04) an aqueous solution of heparin (5-100 ~1, maximal concentration 5 mg/ml) was added. After mixing, the adsorption at 505 nm was measured against a similar solution of Azure A containing no heparin. The weight percentage of heparin in the albumin-heparin conjugates obtained after freeze drying was determined by 2 independent methods, the metachromic assay described above and the uranic acid assay described by Blumenkranz (9).
Determination of Albumin Concentrations
The albumin concentrations of the different column eluates were determined spectrophotometrically (10). The weight percentages of albumin in the albumin-heparin conjugates obtained were determined by the same method. 
Biological

RESULTS
Preparation and Fractionation of Covalently Bound Albumin-Heparin Conjugates
The method developed for coupling albumin and heparin with EDC was based Rechromatography of the freeze dried albumin-heparin conjugate obtained on DEAE-cellulose and Cibacron Blue Sepharose showed that the preparation still contained about 5% free albumin, and no free heparin could be detected. 
Characterization of the Albumin-Heparin Conjugates
The weight % of heparin in the conjugates obtained using identical procedures, varied between 10 and 12% as measured by the 2 calorimetric methods for the determination of heparin as previously described. Non systematic differences in the weight % of heparin up to 0.5% were observed when the results obtained with both methods were compared. When the coupling procedure was performed with a higher ratio of heparin to albumin, purified conjugates contained only a slightly higher weight % of heparin. Representative data are given in Table 1 . 
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The elution patterns of the albumin-heparin conjugate and a mixture of albumin and heparin on Sephacryl S-300 are shown in Figure 3 .
The elution volume of the conjugate on Sephacryl S-300 (exclusion limit 1 x 10s D for globular proteins) is smaller than the elution volume of both heparin and albumin. The fact that the elution profiles coincide shows that the coupling reaction was successful and that the albumin-heparin conjugate is stable at physiological pH. From the results shown in Figure 3 it can be concluded that the molecular weight distribution of the conjugate is rather broad.
The biological activity of the albumin-heparin conjugates was compared with the activity of native heparin. Antithrombin activity (Fig. 4) , antiFactor Xa activity (Fig. 5) The results show that heparin bound to albumin still possesses a substantial heparin activity. Heparin in the albumin-heparin conjugate is more active than unbound heparin when tested with thrombin (ratio 1.25). An activity ratio of 0.5 was measured using a test for Factor Xa inhibition and the APTT test.
Heparin and the albumin-heparin conjugates were fractionated with immobilized antithrombin III to yield portions with low affinity (LA) and high affinity (HA) for antithrombin III. Figure 7 shows the elution profile of the albumin-heparin conjugate on antithrombin III Sepharose. The LA and HA albumin-heparin conjugates obtained as well as LA and HA heparin were characterized by determining the antithrombin activity and the anti-Factor Xa activity (Fig. 8) . 
DISCUSSION
The results presented here demonstrate that albumin-heparin conjugates can be reproducibly synthesized using EDC as a coupling agent. The conjugate contains about 40% of the albumin available for the reaction. EDC activates carboxyl groups which are present in heparin as well as in albumin (99 per  molecule, (16) ). The activated carboxyl groups react almost exclusively with amine groups of albumin. In principle a wide variety of coupling products like alb-hep, alb-alb, alb-alb-hep, hep-alb-hep can be expected. The results presented in Table I show that a variation of the ratio of albumin to heparin in the reaction mixture (0.3-3.0) only leads to small changes in the weight percentage of heparin in the conjugate while the yields were almost the same. This indicates that the carboxyl groups in heparin are more reactive than those in albumin, which might be due to more pronounced shielding of the carboxyl groups in albumin as compared to heparin.
The elution profile of the unpurified albumin-heparin conjugate on DEAEcellulose was measured by determining heparin concentrations and albumin concentrations in the subsequent fractions. Figure 1 shows that after the elution of the column with 0.50 M NaCl, two main peaks were observed, which indicates that albumin-heparin as well as free heparin is present. Further purification was carried out with Cibacron Blue Sepharose. With this material free heparin could be effectively removed, indicating that the heparin moiety in the conjugate doesn't prohibit the binding of the albumin moiety onto Cibacron Blue Sepharose.
The anticoagulant activity of the conjugate is different from that of heparin. As pointed out by Danishefsky et al. (17) , modification of heparin carboxyl groups leads to a decreased anticoagulant activity. In the coupling reaction of albumin and heparin, heparin carboxyl groups are modified and consequently the heparin activity changed. As expected, the anti-Factor Xa activity (Fig. 5) and the activity measured with the APTT assay (Fig. 6 ) of the conjugate, based on the amount of heparin present in the conjugate, is lower (ratio0.5) than native heparin; but in contrast, the antithrombin activity (Fig. 4) As expected, the amide linkage between albumin and heparin is stable. With gel filtration chromatography and rechromatography of purified conjugates no free heparin was detected. However, rechromatography of purified conjugate with DEAE-cellulose showed that the conjugate still contained 5-10% Affinity chromatography with antithrombin III Sepahrose provides heparin fractions with high antithrombin III affinity (and high anticoagulant activity) and with low antithrombin III affinity (and low anticoagulant activity) (12,20,21) . The albumin-heparin conjugates can be fractionated in a similar way into low affinity (LA) and high affinity (HA) conjugates (Fig. 7) , which were compared with unfractionated conjugate by determining the respective antithrombin and anti-Factor Xa activities. Because the antithrombin III column used had a low heparin binding capacity, elution was performed step wise. The weight % of heparin for HA and LA conjugates was 14.1 and 9.5, respectively. The differences in these weight fractions can be explained by the following facts. The ratio of HA to LA increases with increasing average molecular weights of heparin (21) . Therefore, the heparin components of HA conjugates may be of higher average molecular weight than the heparin components of LA conjugates. Consequently, the HA conjugate contains a higher weight % of heparin than either the LA and unfractionated conjugate. The observation that the heparin binding capacity of the antithrombin III column used for fractionation of the conjugate is slightly higher than for native heparin (3.0 mg and 2.8 mg, respectively) support these presumptions.
Current investigations deal with the efficacy of adsorbed albumin-heparin conjugates for the prevention of surface thrombosis.
